Retraction

microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4

Paper Information

Record ID:

32217

Author(s):

Xiaowen Kang
Fanwu Kong
Shijie Wu
Qiushuang Liu
Chengcheng Yang
Xiaomei Wu
Wei Zhang

Journal:

OncoTargets and Therapy ( Taylor and Francis - Dove Press )

Publication Date:

May 28, 2019

Retraction Date:

September 09, 2021 (4.2 years years ago)

Subjects:

Broad Categories:
Biology Genetics

Specific Fields:
Biology - Cancer Biology - Cellular Genetics

Institutions:

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

Taylor and Francis - Dove Press

Open Access:

Yes

DOI:

10.2147/OTT.S204004

PubMed ID:

31213835

Retraction PubMed ID:

34526781

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.2147/OTT.S337587

Citations (28)

28

Total Citations

5

Post-Retraction
(17.9%)

23

Pre-Retraction

0

Same Day

Post-Retraction Citation Analysis

0 Within 30 days

4 Within 1 year

1 After 2+ years

783 Days since retraction (latest)

Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer

Mai Thi Le, Nguyen Thu Huyen, Xuan‐Hung Nguyen et al. (8 authors)

Heliyon Open Access

Published: Nov 2023
8 citations

783 days after retraction

LINC01061 triggers inflammation and inflammasome activation in autoimmune thyroiditis via microRNA-612/BRD4 axis

Yuhang Zhao, Lili Xu, Qing Wang et al. (7 authors)

International Immunopharmacology

Published: Aug 2022
3 citations

345 days after retraction

LINC00174 promotes cell proliferation and metastasis in renal clear cell carcinoma by regulating miR-612/FOXM1 axis

Xiaoshan Li, Wei Liu, Weixiong Tao

Immunopharmacology and Immunotoxicology

Published: May 2022
8 citations

259 days after retraction

PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers

Feng Jiang, Qiaoyi Lv, Cexun Hu et al. (9 authors)

Cancers Open Access

Published: Dec 2021
3 citations

85 days after retraction

Abnormal Circulating Maternal miRNA Expression Is Associated with a Low (<4%) Cell-Free DNA Fetal Fraction

Graziano Santoro, Cristina Lapucci, Marco Giannoccaro et al. (8 authors)

Diagnostics Open Access

Published: Nov 2021
4 citations

66 days after retraction

The Hypoxia–Long Noncoding RNA Interaction in Solid Cancers

Seung Wan Son, Ba Da Yun, Mun Gyu Song et al. (7 authors)

International Journal of Molecular Sciences Open Access

Published: Jul 2021
16 citations

65 days before retraction

RETRACTED: MicroRNA-375-3p in endothelial progenitor cells-derived extracellular vesicles relieves myocardial injury in septic rats via BRD4-mediated PI3K/ AKT signaling pathway

Xiaoyang Hong, Jie Wang, Shuanglei Li et al. (5 authors)

International Immunopharmacology

Published: May 2021
15 citations

113 days before retraction

MAFG-driven osteosarcoma cell progression is inhibited by a novel miRNA miR-4660

Huajian Shan, Lun‐qing Zhu, Chen Yao et al. (9 authors)

Molecular Therapy — Nucleic Acids Open Access

Published: Mar 2021
30 citations

179 days before retraction

Bromodomain-containing protein 4 silencing by microRNA-765 produces anti-ovarian cancer cell activity

Yongjun Ji, Yang Shao, Jie Zhang et al. (5 authors)

Aging Open Access

Published: Mar 2021
8 citations

190 days before retraction

Silencing SIX1 by miR-7160 inhibits non-small cell lung cancer cell growth

Huasi Zhao, Xiaomin Tao, Qun Wang et al. (7 authors)

Aging Open Access

Published: Mar 2021
7 citations

190 days before retraction

Simultaneous microRNA-612 restoration and 5-FU treatment inhibit the growth and migration of human PANC-1 pancreatic cancer cells.

Darya Javadrashid, Reza Mohammadzadeh, Amir Baghbanzadeh et al. (9 authors)

Unknown Journal

Published: Jan 2021
6 citations

251 days before retraction

LncRNA OSER1-AS1 interacts with miR-612/FOXM1 axis to modulate gefitinib resistance of lung adenocarcinoma.

Tingting Shi, Wei-Juan Sun, Yanlong Shi et al. (6 authors)

Unknown Journal

Published: Jan 2021
11 citations

251 days before retraction

LINC00460 Enhances Bladder Carcinoma Cell Proliferation and Migration by Modulating miR-612/FOXK1 Axis

Jianwei Li, Sihuai Huang, Yanmei Zhang et al. (6 authors)

Pharmacology Open Access

Published: Oct 2020
12 citations

337 days before retraction

Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction

Hajar Alemohammad, Zahra Asadzadeh, rohollah motafakker azad et al. (8 authors)

Life Sciences

Published: Aug 2020
19 citations

383 days before retraction

<p>LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis</p>

Guanbin Qi, Lei Li

OncoTargets and Therapy Open Access

Published: Jun 2020
19 citations

436 days before retraction

Clinical Value of Serum LHPP-associated miR-765 in the Prognosis of Laparoscopic or Open Hepatectomy for Hepatocellular Carcinoma

Jingting Yan, Liyan He, Guang Li et al. (10 authors)

Surgical Laparoscopy Endoscopy & Percutaneous Techniques Open Access

Published: May 2020
7 citations

485 days before retraction

MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancer

Yitao Wang, Feifei Jiang, Jian Wang et al. (6 authors)

Cancer Biomarkers

Published: Mar 2020
4 citations

534 days before retraction

Ultrasound‑targeted microbubble destruction‑mediated miR‑767 inhibition suppresses tumor progression of non‑small cell lung cancer

Xiaohua Li, Min Xu, Wenyu Lv et al. (4 authors)

Experimental and Therapeutic Medicine Open Access

Published: Mar 2020
10 citations

546 days before retraction

Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p

Gang Cao, Bing Tan, Shanzhen Wei et al. (8 authors)

Biomedicine & Pharmacotherapy Open Access

Published: Feb 2020
22 citations

563 days before retraction

MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression

Jiangnan Zheng, Yan Zhang, Shang Cai et al. (7 authors)

Cancer Letters

Published: Feb 2020
28 citations

570 days before retraction

LncRNA NNT‐AS1 promotes non‐small cell lung cancer progression through regulating miR‐22‐3p/YAP1 axis

Wenlong He, Yeying Zhang, Shulan Xia

Thoracic Cancer Open Access

Published: Jan 2020
39 citations

608 days before retraction

Clinical value of CTLA4-associated microRNAs combined with inflammatory factors in the diagnosis of non-small cell lung cancer

Xiaohong Liu, Chun‐lian Tang, Xianda Song et al. (10 authors)

Annals of Clinical Biochemistry International Journal of Laboratory Medicine Open Access

Published: Jan 2020
8 citations

611 days before retraction

SNHG9 was upregulated in NSCLC and associated with DDP-resistance and poor prognosis of NSCLC patients.

Ruixue Wang, Changyu Chen, Weibiao Kang et al. (4 authors)

PubMed

Published: Jan 2020
19 citations

617 days before retraction

MiR‐148b suppressed non‐small cell lung cancer progression via inhibiting ALCAM through the NF‐κB signaling pathway

Zhe Jiang, Jingwen Zhang, Fuhui Chen et al. (4 authors)

Thoracic Cancer Open Access

Published: Dec 2019
20 citations

622 days before retraction

microRNA: The Impact on Cancer Stemness and Therapeutic Resistance

Xueqiao Jiao, Xianling Qian, Longyuan Wu et al. (7 authors)

Cells Open Access

Published: Dec 2019
55 citations

631 days before retraction

MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells

Zhonghai Du, Jun Wu, Juan Wang et al. (7 authors)

Diagnostic Pathology Open Access

Published: Dec 2019
14 citations

648 days before retraction

Clinical value of LHPP‐associated microRNAs combined with protein induced by vitamin K deficiency or antagonist‐II in the diagnosis of alpha‐fetoprotein‐negative hepatocellular carcinoma

Zeyu Tian, Tanbo Yu, Hongyan Wei et al. (4 authors)

Journal of Clinical Laboratory Analysis Open Access

Published: Nov 2019
15 citations

673 days before retraction

MicroRNA-647 promotes the therapeutic effectiveness of argon&ndash;helium cryoablation and inhibits cell proliferation through targeting TRAF2 via the NF-&kappa;B signaling pathway in non-small cell lung cancer

Yunsong Zhang, Tianzi Chen, Ying Cai et al. (9 authors)

OncoTargets and Therapy Open Access

Published: Oct 2018
15 citations

1074 days before retraction

Quick Stats

Total Citations: 28

Years Since Retraction: 4.2 years

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice